Automate Your Wheel Strategy on CNC
With Tiblio's Option Bot, you can configure your own wheel strategy including CNC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CNC
- Rev/Share 341.1512
- Book/Share 56.4656
- PB 0.5781
- Debt/Equity 0.6563
- CurrentRatio 1.1116
- ROIC 0.055
- MktCap 16182049560.0
- FreeCF/Share 3.0068
- PFCF 10.8459
- PE 4.6733
- Debt/Assets 0.2105
- DivYield 0
- ROE 0.1267
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 3
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | CNC | Morgan Stanley | Overweight | Equal Weight | -- | $33 | July 10, 2025 |
| Downgrade | CNC | UBS | Buy | Neutral | -- | $45 | July 2, 2025 |
| Downgrade | CNC | JP Morgan | Overweight | Neutral | -- | $48 | July 2, 2025 |
| Resumed | CNC | Morgan Stanley | -- | Overweight | -- | $70 | June 9, 2025 |
| Downgrade | CNC | Barclays | Overweight | Equal Weight | -- | $65 | June 2, 2025 |
| Upgrade | CNC | Jefferies | Underperform | Hold | -- | $64 | April 8, 2025 |
| Downgrade | CNC | Argus | Buy | Hold | -- | -- | Feb. 6, 2025 |
| Resumed | CNC | JP Morgan | -- | Overweight | $80 | $75 | Dec. 17, 2024 |
| Upgrade | CNC | UBS | Neutral | Buy | $79 | $80 | Dec. 13, 2024 |
| Downgrade | CNC | Jefferies | Hold | Underperform | $68 | $52 | Dec. 10, 2024 |
News
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Centene Corporation (CNC) Investors To Inquire About Securities Fraud Class Action
Published: July 11, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) securities between December 12, 2024 to June 30, 2025, inclusive (the “Class Period”). Centene investors have until September 8, 2025 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS ON YOUR.
Read More
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Centene Corporation (CNC)
Published: July 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) securities between December 12, 2024 and June 30, 2025, both dates inclusive (the “Class Period”).
Read More
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centene
Published: July 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Centene To Contact Him Directly To Discuss Their Options
Read More
INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Centene Corporation (CNC) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: July 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the Centene class action lawsuit – captioned Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.) – seeks to represent purchasers or acquirers of Centene Corporation (NYSE: CNC) securities and charges Centene and certain of Centene's executives with violations of the Securities Exchange Act of 1934.
Read More
Shareholders that lost money on Centene Corporation(CNC) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Published: July 11, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , July 11, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Centene investors who were adversely affected by alleged securities fraud between December 12, 2024 and June 30, 2025.
Read More
CNC BREAKING CLASS ACTION: Centene Corporation has been Sued for Securities Fraud; Investors with Losses are Notified to Contact BFA Law by September 8 Court Deadline (NYSE:CNC)
Published: July 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Centene Corporation (NYSE: CNC) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Centene, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/centene-corporation-class-action-lawsuit.
Read More
Law Offices of Howard G. Smith Encourages Centene Corporation (CNC) Investors To Inquire About Securities Fraud Class Action
Published: July 10, 2025 by: Business Wire
Sentiment: Neutral
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) securities between December 12, 2024 to June 30, 2025, inclusive (the “Class Period”). Centene investors have until September 8, 2025 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CENTENE CORPORATION (CNC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO.
Read More
CENTENE CORPORATION (NYSE: CNC) INVESTOR ALERT: Investors With Large Losses in Centene Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights
Published: July 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) between December 12, 2024 and June 30, 2025, inclusive. For more information, submit a form at Centene Corporation Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030.
Read More
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Centene Corporation Securities and Sets a Lead Plaintiff Deadline of September 8, 2025
Published: July 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) between December 12, 2024 to June 30, 2025, both dates inclusive. You are hereby notified that the class action lawsuit Brock Lunstrum v.
Read More
Shareholder Alert: Robbins LLP Informs Investors of the Centene Corporation Class Action
Published: July 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Centene Corporation (NYSE: CNC) securities between December 12, 2024 and June 30, 2025. Centene describes itself as a leading healthcare enterprise that is committed to helping people live healthier lives.
Read More
Centene's Punishment Overly Done - Contrarian Buy At A Deep Discount
Published: July 08, 2025 by: Seeking Alpha
Sentiment: Neutral
CNC has been deeply punished for the suspended FY2025 adj EPS guidance, after supposedly reiterating the prior numbers in the FQ1'25 earnings call. It is apparent that the higher medical care activities have impacted the healthcare providers'/ insurance's bottom-lines, worsened by the headwinds arising from One Big Beautiful Bill. Even so, the worst may already be baked into CNC's overly discounted valuations / stock prices, with the normalization likely to trigger rich upside potentials to its current BV of $56.11.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Centene Corporation - CNC
Published: July 07, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , July 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Centene Corporation ("Centene" or the "Company") (NYSE: CNC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
Centene Corporation (CNC) Investors See Over $11 Billion Of Shareholder Value Wiped Out In 1 Day Amid Independent Actuary Data, Withdrawn 2025 Guidance- Hagens Berman
Published: July 07, 2025 by: PRNewsWire
Sentiment: Neutral
SAN FRANCISCO , July 7, 2025 /PRNewswire/ -- On July 2, 2025, investors in Centene Corp. (NYSE: CNC) saw the price of their shares of this normally low-volatility stock crash 40%, after the company withdrew its guidance, blaming preliminary discussions and data generated by an independent actuary, Wakely. The unusual circumstances and severe investor reaction has prompted national shareholders rights firm Hagens Berman to open an investigation into whether Centene may have violated the securities laws.
Read More
Centene's 40% Crash: Generational Buy Or Value Trap?
Published: July 03, 2025 by: Seeking Alpha
Sentiment: Neutral
Centene's 40% drop after pulling 2025 guidance is driven by rising medical costs and margin pressure, but the sell-off appears overdone. Historical patterns show that similar sell-offs in 2016 and 2020 were followed by recoveries as premiums were adjusted upward. Valuation is now highly attractive, with Price/Cash Flow below 8, making CNC stock a compelling buy despite sector volatility.
Read More
Jim Cramer on what is behind Centene's 40% drop
Published: July 02, 2025 by: CNBC Television
Sentiment: Negative
'Mad Money' host Jim Cramer dissects Centene's massive plummet following earnings.
Read More
S&P 500 Gains and Losses Today: Centene Pulls Guidance, Health Insurance Stocks Fall
Published: July 02, 2025 by: Investopedia
Sentiment: Negative
Major U.S. equities indexes finished Wednesday mixed as President Donald Trump announced that the U.S. has reached a trade deal with Vietnam.
Read More
Centene Faces Earnings Crunch as More Healthy Americans Exit Insurance Plans
Published: July 02, 2025 by: WSJ
Sentiment: Negative
The health-insurance provider is reckoning with multiple threats to its business, potentially leaving it with fewer and less-healthy enrollees signed up to its health-insurance plans.
Read More
Centene Tells United Healthcare To Hold Its Beer
Published: July 02, 2025 by: Seeking Alpha
Sentiment: Negative
Centene's stock plunged after slashing 2025 EPS guidance due to higher-than-expected morbidity and lower market growth in key states. The company's previous bullish guidance failed to materialize. Despite the sharp drop, Centene trades at historically low price-to-sales multiples and investment grade status, making valuation attractive for risk-tolerant investors.
Read More
Securities Fraud Investigation Into Centene Corporation (CNC) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Published: July 02, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CENTENE CORPORATION (CNC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On July 1, 2025, Centene announced that it was withdrawing its previo.
Read More
Centene shares plummet as it withdraws full-year guidance
Published: July 02, 2025 by: Proactive Investors
Sentiment: Negative
Centene Corp (NYSE:CNC) shares fell almost 40% after the healthcare company withdrew its full-year 2025 financial guidance due to weak growth and higher-than-expected costs in its Affordable Care Act (ACA) marketplace business. Based on a preliminary analysis from the independent actuarial firm Wakely, Centene anticipates a $1.8 billion shortfall in risk adjustment revenue for 2025, which translates to a $2.75 per share reduction in adjusted earnings.
Read More
Centene Pulls 2025 Guidance as Marketplace Growth Falters
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Negative
CNC pulls its 2025 forecast after a $1.8B risk adjustment shortfall. Also, weak Marketplace growth shakes investor confidence.
Read More
4 Value Stocks to Invest in for the Second-Half 2025 Market Shift
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Hudbay, StoneCo, Centene, and CVS stand out as top value picks for H2 2025 with strong cash flow and growth prospects.
Read More
CNC Hits 8-Year Low, Big Banks Boost Dividends, STZ Earnings Rally
Published: July 02, 2025 by: Schwab Network
Sentiment: Negative
Centene (CNC) sold off more than 30% at the opening bell after withdrawing full-year guidance. Diane King Hall talks about how the "big, beautiful bill" plays a pivotal role in that downside price action.
Read More
Is Centene (CNC) Stock Undervalued Right Now?
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
5 Low Price-to-Book Value Stocks to Buy in July for Solid Returns
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, ODP, STNE and PSFE are some such stocks.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Read More
Centene (CNC) Loses 5.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Published: June 27, 2025 by: Zacks Investment Research
Sentiment: Negative
Centene (CNC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Read More
4 HMO Stocks Set to Thrive From Steady Premium Flows, M&A Strategy
Published: June 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Rising premiums, ongoing technological innovation and the growing demand for Medicare plans are anticipated to propel the performance of the Zacks Medical-HMO industry players. CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
Read More
Health Net Providing Special Assistance to Members and Providers Affected by The Franklin Fire in Malibu Canyon in the City of Malibu, California
Published: June 20, 2025 by: PRNewsWire
Sentiment: Neutral
SACRAMENTO, Calif. , June 20, 2025 /PRNewswire/ -- Following Gov.
Read More
Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks
Published: June 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Top-ranked stocks Centene (CNC), Astera Labs Inc. (ALAB), Five9 (FIVN), Uber Technologies (UBER) and Voya Financial (VOYA) are likely to beat on the bottom line in their upcoming releases.
Read More
About Centene Corporation (CNC)
- IPO Date 2001-12-13
- Website https://www.centene.com
- Industry Medical - Healthcare Plans
- CEO Sarah M. London
- Employees 60400